Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
SIGA Technologies, Inc.
Biological Products Except Diagnostic Substances NY, United States
Nasdaq: SIGA
Company Description
SIGA Technologies, Inc. is a pharmaceutical company. It is engaged in the development and commercialization of therapeutic solutions for some of the lethal disease causing pathogens - smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. The company's business is to discover, develop, manufacture and successfully commercialize drugs to prevent and treat these high priority threats. Its product, ST-246, is an orally administered antiviral drug that targets orthopoxviruses. The company's focuses to disarm dreaded viral diseases and create robust, modern biodefense countermeasures. SIGA Technologies was founded on December 28, 1995 and is headquartered in New York, NY.
Similar to: BioTime, Inc., ALLENEX AB, Cardium Therapeutics, Inc.
Featured Company
Kindred Healthcare, Inc.
Louisville, KY, US
Kindred Healthcare, Inc., a top-125 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville,… Learn more →
Social Monitor
You may also be interested in:
Cardium Therapeutics, Inc.
San Diego, CA, US
Cardium Therapeutics, Inc. is an asset-based, health sciences and regenerative medicine company focused on acquiring and strategically… Learn more →
ALLENEX AB
Stockholm, SE
Allenex is a life science-company that develops, manufacture, market and sell products for safer transplants of organs and bone marrow… Learn more →
BioTime, Inc.
Alameda, CA, US
BioTime, Inc. is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of… Learn more →